Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and lipofectamine

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with lipofectamine in 1 studies

Compound Research Comparison

Studies
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)
Trials
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)
Recent Studies (post-2010)
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)
Studies
(lipofectamine)
Trials
(lipofectamine)
Recent Studies (post-2010) (lipofectamine)
638312436630301

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arbab, AS; Bryant, LH; Bulte, JW; Frank, JA; Kalish, H; Lewis, BK; Miller, BR; Zywicke, HA1

Other Studies

1 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and lipofectamine

ArticleYear
Combination of transfection agents and magnetic resonance contrast agents for cellular imaging: relationship between relaxivities, electrostatic forces, and chemical composition.
    Magnetic resonance in medicine, 2003, Volume: 50, Issue:2

    Topics: Cells, Cultured; Contrast Media; Dextrans; Electrochemistry; Ferrosoferric Oxide; Gadolinium; Heterocyclic Compounds; Hydrogen-Ion Concentration; Iron; Lipids; Magnetic Resonance Imaging; Magnetite Nanoparticles; Organometallic Compounds; Oxides; Transfection

2003